Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...

In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.